Inflacalm SAP
Natural health product licensed in Canada
- Licence holder
- Nutritional Fundamentals for Health Inc.
- NPN or DIN-HM
- 80087747
- Status
- Active licence
- Licence date
- 13 August 2018
- Revision date
- 28 September 2026
- Form
- Capsule, libération-retardée
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- À vérifier
Serratiopeptidase is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
POL-NF-00692. Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Piper nigrum Source : Fruit Extraction ratio : 25:1 Dry plant equivalent : 37.5 mg Potency : 95 % Piperine | 1.5 mg | Not calculated |
| 3,3',4',5,7-pentahydroxyflavone Source : Styphnolobium japonicum - fleur | 100 mg | Not calculated |
| Serratiopeptidase Source : Serratia marcescens E-15 - Cellule Entiière Potency : 48,000 SU | 20 mg | Not calculated |
| Curcuma longa Source : Rhizome Extraction ratio : 6:1 Dry plant equivalent : 900 mg Potency : 10 % Curcuminoids | 150 mg | Not calculated |
| 3-(O-6-désoxy-alpha-l-mannopyranosyl-(1-6)-bêta-d-glucopyranosyloxy)-2-(3,4-dihydroxyphényl)-5,7-dihydroxy-4H-chromen-4-one Source : Styphnolobium japonicum - fleur | 100 mg | Not calculated |
Non-medicinal ingredients
Alginate de sodium, NA, Dioxyde de silicium, Hypromellose acetate succinate, Oleic acid, Hypromellose, Eau purifiée, Stéarate de magnésium, Éthylcellulose, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides antioxidants for the maintenance of good health. Used in herbal medicine to help relieve minor pain, swelling and inflammation (anti-inflammatory). Helps to reduce (symptoms such as) pain, quantity of secretion, inability to perceive smell and stuffy nose from ear, nose and throat infections. Mucolytic enzyme. Digestive enzymes. Helps reduce and/or relieve postoperative cheek swelling and/or pain after dental surgery.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80087747
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.